| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 42 | 4.548 | 9.858 | 12.937 | 29.008 | 36.362 |
| Total Income - EUR | - | - | - | - | 42 | 4.548 | 9.858 | 12.937 | 29.008 | 36.382 |
| Total Expenses - EUR | - | - | - | - | 1.409 | 1.459 | 2.457 | 3.348 | 11.596 | 18.133 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.367 | 3.090 | 7.402 | 9.588 | 17.412 | 18.248 |
| Net Profit/Loss - EUR | - | - | - | - | -1.368 | 2.951 | 7.136 | 9.292 | 17.136 | 17.888 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Medicina Integrativa Prin Recalibrarea Fiintei S.r
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.569 | 938 | 329 | 1.343 | 574 | 963 |
| Current Assets | - | - | - | - | 260 | 4.591 | 7.640 | 15.341 | 25.412 | 40.107 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 224 | 5.759 | 10.634 | 22.893 | 39.523 |
| Cash | - | - | - | - | 260 | 4.366 | 1.882 | 4.707 | 2.518 | 584 |
| Shareholders Funds | - | - | - | - | -1.326 | 1.650 | 7.184 | 9.340 | 17.185 | 34.977 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.156 | 3.878 | 785 | 7.343 | 8.801 | 6.093 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Medicina Integrativa Prin Recalibrarea Fiintei S.r.l.